Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort.

Department of Neurology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Neurology (Impact Factor: 8.25). 10/2009; 73(15):1180-5. DOI: 10.1212/WNL.0b013e3181bbff05
Source: PubMed

ABSTRACT Mutations in the FUS gene on chromosome 16 have been recently discovered as a cause of familial amyotrophic lateral sclerosis (FALS). This study determined the frequency and identities of FUS gene mutations in a cohort of Italian patients with FALS.
We screened all 15 coding exons of FUS for mutations in 94 Italian patients with FALS.
We identified 4 distinct missense mutations in 5 patients; 2 were novel. The mutations were not present in 376 healthy Italian controls and thus are likely to be pathogenic.
Our results demonstrate that FUS mutations cause approximately 4% of familial amyotrophic lateral sclerosis cases in the Italian population.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Essential tremor (ET) is a prevalent neurological disorder of unknown etiology characterized by the presence of an action tremor that occurs during voluntary motion and affects primarily the upper limbs. The worldwide prevalence of the disease in the general population is 0.9%, increasing to 4.6% in individuals ≥ 65 years old. Standard pharmaceutical treatments are only moderately effective, reducing tremor amplitudes in ∼ 50% of patients, a phenomenon partly explained by the fact that the diagnosis of ET is based solely on clinical findings rather than biological markers. Furthermore, the pathophysiological origin of ET remains controversial, leading to heated debates as to whether it should be considered a neurodegenerative disorder or as a dynamic oscillatory disturbances of neurologic origin. Progress has been made in the understanding of its etiology as it is now accepted that genetic components must at least explain the familial cases of ET, and the evidence implicating the olivocerebellar and cerebello-thalamo-cortical pathways is strong. However, a strong disconnection between human genetics, pathophysiological, and mouse genetics studies exists in the field of ET, with little use of all the knowledge gathered from the different research disciplines. This review highlights our current knowledge on ET from both a human population and mouse genetics perspective hoping to reconcile evidence from both fields and leading to novel clues guiding future studies. We argue that better communication between researchers of different fields is warranted to define the biological origin of ET in the hope of leading to the development of better treatments.
    Progress in Neurobiology 05/2014; · 9.04 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Amyotrophic lateral sclerosis 6 (ALS6) is an autosomal recessive disorder caused by heterozygous mutation in Fused in Sarcoma (FUS) gene. ALS6 is a neurodegenerative disorder which affects the upper and lower motor neurons in the brain and spinal cord and resulting in fatal paralysis. ALS6 is caused by the genetic mutation in the proline/tyrosine-nuclear localization signals (PY-NLS) of the Fused in sarcoma Protein (FUS). FUS gene also known as TLS (Translocated in liposarcoma) which encodes a protein called RNA-binding protein-Fus (FUS) has a molecular weight of 75kDa. In this analysis we applied computational approach to filter the most deleterious and neurodegenerative disease of ALS6 associated mutation on FUS protein. We found H517Q as most deleterious and disease-associated by PolyPhen 2.0, I-Mutant 3.0, SIFT, SNPs&GO, PhD-SNP, Pmut and Mutpred tools. Molecular dynamics simulation (MDS) approach was conducted to investigate conformational changes in the mutant protein structure with respect to its native conformation. MDS results showed the flexibility loss in mutant (H517Q) FUS protein. Due to mutation, FUS protein became more rigid in nature and might alters the structural and functional behaviour of protein and play a major role in inducing ALS6. The results obtained from this investigation would help in the field of pharmacogenomics to develop a potent drug target against FUS associated neurodegenerative diseases.
    Journal of biomolecular structure & dynamics 04/2014; · 4.99 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The neurodegenerative diseases are a diverse group of disorders characterized by progressive loss of specific groups of neurons. These diseases affect different populations, and have a variable age of onset, clinical symptoms, and pathological findings. Variants in the FUS gene, which encodes an RNA-binding protein, have been identified as causative or risk factors for amyotrophic lateral sclerosis (ALS), essential tremor and rare forms of frontotemporal lobar degeneration (FTLD). Additionally, abnormal aggregation of FUS protein has been reported in multiple neurodegenerative diseases, including ALS, FTLD and the polyglutamine diseases, suggesting a role for FUS in the pathogenesis of these neurodegenerative diseases. This Review summarizes current understanding of the normal function of FUS, and describes its role in the pathology of ALS, FTLD, essential tremor and other neurodegenerative diseases. Comments on the underlying pathogenetic mechanisms of these FUS-related disorders are included. Finally, the clinical implications of recent advances in FUS research are discussed. Further understanding of the role of FUS in neurodegenerative diseases might lead to improvements in the treatment and prevention of these disorders.
    Nature Reviews Neurology 05/2014; · 15.52 Impact Factor


Available from